Isracann Biosciences Inc. (ISCNF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 2, 2025
Isracann Biosciences Balance Sheet
Financials in millions CAD. Fiscal year is June - May.
Millions CAD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Aug '22 Aug 31, 2022 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | May '19 May 31, 2019 |
Cash & Equivalents | 0.2 | 0.21 | 1.96 | 3.89 | 4.18 |
Cash & Short-Term Investments | 0.2 | 0.21 | 1.96 | 3.89 | 4.18 |
Cash Growth | -85.84% | -89.08% | -49.67% | -6.87% | - |
Other Receivables | 0.08 | 0.08 | 0.21 | 0.24 | 0.18 |
Receivables | 0.08 | 0.08 | 0.21 | 0.24 | 0.68 |
Prepaid Expenses | 0.02 | 0.05 | 0.08 | 0.18 | 0.44 |
Restricted Cash | - | - | - | - | 10.15 |
Other Current Assets | - | - | - | 1.16 | - |
Total Current Assets | 0.3 | 0.34 | 2.25 | 5.48 | 15.45 |
Property, Plant & Equipment | 0.04 | 0.05 | 0.09 | 0.12 | 0.89 |
Long-Term Investments | - | - | 0.25 | 0.27 | - |
Other Intangible Assets | 3.7 | 3.7 | - | 20.62 | - |
Long-Term Deferred Charges | - | - | - | - | 0.03 |
Other Long-Term Assets | - | - | 1.29 | 1.3 | - |
Total Assets | 4.04 | 4.09 | 4.4 | 28.27 | 16.37 |
Accounts Payable | 0.4 | 0.31 | 0.45 | 0.71 | 0.93 |
Accrued Expenses | 0.63 | 0.61 | 0.01 | 0.05 | 0.1 |
Other Current Liabilities | - | - | - | 0.97 | - |
Total Current Liabilities | 1.03 | 0.92 | 0.47 | 1.72 | 1.04 |
Other Long-Term Liabilities | 2.89 | 2.89 | - | - | - |
Total Liabilities | 3.91 | 3.8 | 0.47 | 1.72 | 1.04 |
Common Stock | 63.1 | 62.87 | 62.01 | 56.89 | 11.74 |
Retained Earnings | -77.14 | -76.82 | -72.13 | -43.79 | -19.59 |
Comprehensive Income & Other | 14.17 | 14.25 | 14.06 | 13.45 | 23.18 |
Total Common Equity | 0.13 | 0.29 | 3.94 | 26.56 | 15.33 |
Minority Interest | -0 | -0 | -0 | -0 | - |
Shareholders' Equity | 0.12 | 0.29 | 3.94 | 26.56 | 15.33 |
Total Liabilities & Equity | 4.04 | 4.09 | 4.4 | 28.27 | 16.37 |
Net Cash (Debt) | 0.2 | 0.21 | 1.96 | 3.89 | 4.18 |
Net Cash Growth | -85.84% | -89.08% | -49.67% | -6.87% | - |
Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.04 | 0.11 |
Filing Date Shares Outstanding | 175.99 | 175.99 | 146.08 | 134.19 | 38.31 |
Total Common Shares Outstanding | 162.97 | 158.29 | 146.08 | 134.19 | 38.31 |
Working Capital | -0.73 | -0.57 | 1.79 | 3.76 | 14.41 |
Book Value Per Share | 0.00 | 0.00 | 0.03 | 0.20 | 0.40 |
Tangible Book Value | -3.57 | -3.4 | 3.94 | 5.94 | 15.33 |
Tangible Book Value Per Share | -0.02 | -0.02 | 0.03 | 0.04 | 0.40 |
Land | - | - | - | - | 0.06 |
Buildings | 0.07 | 0.07 | 0.07 | 0.07 | 3.44 |
Machinery | 0.14 | 0.14 | 0.14 | 0.13 | 0.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.